Search Results - "GANDA, O. P"
-
1
Quantification of concordance and discordance between apolipoprotein-B and the currently recommended non-HDL-cholesterol goals for cardiovascular risk assessment in patients with diabetes and hypertriglyceridemia
Published in Diabetes research and clinical practice (01-07-2012)“…Abstract Aims In patients with diabetes and hypertriglyceridemia, LDL-cholesterol (LDL-C) provides an inaccurate reflection of LDL particle burden. The…”
Get full text
Journal Article -
2
Lipoatrophy, lipodystrophy, and insulin resistance
Published in Annals of internal medicine (15-08-2000)Get full text
Journal Article -
3
Hyperfibrinogenemia. An important risk factor for vascular complications in diabetes
Published in Diabetes care (01-10-1992)“…Hyperfibrinogenemia. An important risk factor for vascular complications in diabetes. O P Ganda and C F Arkin Joslin Diabetes Center, Boston, MA 02215…”
Get full text
Journal Article -
4
Pre-type I diabetes. Linear loss of beta cell response to intravenous glucose
Published in Diabetes (New York, N.Y.) (01-08-1984)“…Pre-type I diabetes. Linear loss of beta cell response to intravenous glucose. S Srikanta , O P Ganda , R E Gleason , R A Jackson , J S Soeldner and G S…”
Get full text
Journal Article -
5
First-degree relatives of patients with type I diabetes mellitus. Islet-cell antibodies and abnormal insulin secretion
Published in The New England journal of medicine (22-08-1985)“…In a prospective study to evaluate the prevalence and predictive potential of circulating islet-cell antibodies, we have screened 1723 "normal" first-degree…”
Get more information
Journal Article -
6
Type I diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunction
Published in Annals of internal medicine (01-09-1983)“…In a prospective 21-year study, islet cell antibodies and beta cell function were serially assessed in 24 monozygotic twins initially discordant for type I…”
Get more information
Journal Article -
7
Differential sensitivity to β-cell secretagogues in early, type I diabetes mellitus
Published in Diabetes (New York, N.Y.) (01-06-1984)“…The insulin secretory response to various beta-cell secretagogues was studied in four children (ages 11, 11, 12, and 10 yr) in "early" stages or remission of…”
Get full text
Journal Article -
8
Efficacy and safety of pravastatin in the treatment of patients with type I or type II diabetes mellitus and hypercholesterolemia
Published in The American journal of medicine (01-10-1995)“…Patients with type I and type II diabetes mellitus have an increased risk of coronary heart disease. In many diabetics, hypercholesterolemia is present and…”
Get more information
Journal Article -
9
Differential sensitivity to beta-cell secretagogues in "early," type I diabetes mellitus
Published in Diabetes (New York, N.Y.) (01-06-1984)“…Differential sensitivity to beta-cell secretagogues in "early," type I diabetes mellitus. O P Ganda , S Srikanta , S J Brink , M A Morris , R E Gleason , J S…”
Get full text
Journal Article -
10
Hypertension: the major risk factor in juvenile-onset insulin-dependent diabetics
Published in Diabetes (New York, N.Y.) (01-01-1981)“…The prevalence of hypertension in various age groups of diabetics and its role as a risk factor in juvenileonset insulin-dependent diabetics followed for 40 yr…”
Get full text
Journal Article -
11
Microalbuminuria: measurements, determinants and accompaniments
Published in Diabetes research and clinical practice (01-03-1991)Get more information
Journal Article -
12
Pentamidine and hypoglycemia
Published in Annals of internal medicine (01-03-1984)Get more information
Journal Article -
13
The effect of physical training on glucose tolerance and plasma lipids in maturity-onset diabetes
Published in Diabetes (New York, N.Y.) (01-01-1979)Get full text
Journal Article -
14
The role of gastrointestinal and neuronal peptides in the pathophysiology of diabetes mellitus
Published in Diabetes care (01-05-1981)“…The role of gastrointestinal and neuronal peptides in the pathophysiology of diabetes mellitus. O P Ganda Abstract The pancreatic islet hormone secretion is…”
Get full text
Journal Article -
15
Alterations in plasma lipids in the presence of mild glucose intolerance in the offspring of two type II diabetic parents
Published in Diabetes care (01-05-1985)“…Alterations in plasma lipids in the presence of mild glucose intolerance in the offspring of two type II diabetic parents. O P Ganda , J S Soeldner and R E…”
Get full text
Journal Article -
16
Different effects of duration on prevalence of anti-adrenal medullary and pancreatic islet cell antibodies in type I diabetes mellitus
Published in Hormone and metabolic research (01-08-1989)“…Autoimmunity is a known factor in the pathogenesis of islet cell destruction, but little is known of its role in the pathogenesis of the neuronal complications…”
Get more information
Journal Article -
17
Pancreatic somatostatinoma: abundance of somatostatin-28(1-12)-like immunoreactivity in tumor and plasma
Published in The journal of clinical endocrinology and metabolism (01-11-1983)“…In the present study we characterized and compared the relative amounts of the different molecular forms of somatostatin-14 like immunoreactivity (S-14 LI) and…”
Get more information
Journal Article -
18
Studies on streptozotocin diabetes
Published in Diabetes (New York, N.Y.) (01-07-1976)“…Studies on streptozotocin diabetes. O P Ganda , A A Rossini and A A Like Abstract Both alloxan and streptozotocin produce beta-cell necrosis in the rat…”
Get full text
Journal Article -
19
Diminished A-cell secretion in the early phase of type I diabetes mellitus
Published in Metabolism, clinical and experimental (01-11-1986)“…The A-cell function in "true pre-type I diabetes" or in early phase of type I diabetes has not been reported. We studied A-cell reserve in response to…”
Get more information
Journal Article -
20
Reproducibility and comparative analysis of repeated intravenous and oral glucose tolerance tests
Published in Diabetes (New York, N.Y.) (01-07-1978)“…We have developed a methodology for measuring the reproducibility of the oral glucose tolerance test (OGTT) and the intravenous glucose tolerance test (IVGTT)…”
Get full text
Journal Article